These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32690637)

  • 1. Differential Induction of Type I and III Interferons by
    Peignier A; Planet PJ; Parker D
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32690637
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy.
    Basco MDS; Kothari A; McKinzie PB; Revollo JR; Agnihothram S; Azevedo MP; Saccente M; Hart ME
    J Med Microbiol; 2019 Jun; 68(6):848-859. PubMed ID: 31136294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VraR Binding to the Promoter Region of
    Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An induced mutation of ABC-transporter component VraF(K84E) contributes to vancomycin resistance and virulence in Staphylococcus aureus strain MW2.
    Cao R; Su H; Wei Z; He Z; Pan T; Li Y; Sun B
    Int J Med Microbiol; 2024 Jun; 315():151624. PubMed ID: 38838390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus.
    Rao Y; Peng H; Shang W; Hu Z; Yang Y; Tan L; Li M; Zhou R; Rao X
    J Adv Res; 2022 Sep; 40():167-178. PubMed ID: 36100324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Drug Resistance of
    Luan W; Liu X; Wang X; An Y; Wang Y; Wang C; Shen K; Xu H; Li S; Liu M; Yu LU
    Pol J Microbiol; 2019 Dec; 68(4):477-491. PubMed ID: 31880892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility.
    Jansen A; Szekat C; Schröder W; Wolz C; Goerke C; Lee JC; Türck M; Bierbaum G
    BMC Microbiol; 2013 Mar; 13():65. PubMed ID: 23522028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains.
    Parker D; Planet PJ; Soong G; Narechania A; Prince A
    PLoS Pathog; 2014 Feb; 10(2):e1003951. PubMed ID: 24586160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin-resistant and vancomycin-intermediate Staphylococcus aureus colonizing patients and intensive care unit environment: virulence profile and genetic variability.
    Veloso JO; Lamaro-Cardoso J; Neves LS; Borges LFA; Pires CH; Lamaro L; Guerreiro TC; Ferreira EMA; André MCP
    APMIS; 2019 Nov; 127(11):717-726. PubMed ID: 31407405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Activity of Galangin and Its Effects on Murein Hydrolases of Vancomycin-Intermediate Staphylococcus aureus (VISA) Strain Mu50.
    Ouyang J; Sun F; Feng W; Xie Y; Ren L; Chen Y
    Chemotherapy; 2018; 63(1):20-28. PubMed ID: 29145175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress resistance and fitness-compensatory response in vancomycin-intermediate
    Tan XE; Neoh HM; Cui L; Hiramatsu K; Jamal R
    Can J Microbiol; 2019 Aug; 65(8):623-628. PubMed ID: 31063703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
    Boyle-Vavra S; Carey RB; Daum RS
    J Antimicrob Chemother; 2001 Nov; 48(5):617-25. PubMed ID: 11679550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of bi-component leukocidin and drug resistance in nasal and clinical Staphylococcus aureus in Lagos, Nigeria.
    Enwuru NV; Adesida SA; Enwuru CA; Ghebremedhin B; Mendie UE; Coker AO
    Microb Pathog; 2018 Feb; 115():1-7. PubMed ID: 29246634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation of walK confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus.
    Zhu J; Liu B; Shu X; Sun B
    Int J Med Microbiol; 2021 Feb; 311(2):151473. PubMed ID: 33445057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation.
    Park C; Shin NY; Byun JH; Shin HH; Kwon EY; Choi SM; Kim SH; Kwon JC; Park SH; Choi JH; Yoo JH; Yoo JI; Chung GT; Lee DG
    J Med Microbiol; 2012 Mar; 61(Pt 3):345-352. PubMed ID: 22016559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.